125 related articles for article (PubMed ID: 20651396)
1. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.
Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Falco E; Fontana V; Gianquinto D; Pistillo MP; Fedeli F; Roncella S
Anticancer Res; 2010 Jun; 30(6):2377-82. PubMed ID: 20651396
[TBL] [Abstract][Full Text] [Related]
2. [Detection of mammaglobin mRNA as a marker for circulating tumor cells in breast carcinoma].
Zach O; Kasparu H; Wagner H; Krieger O; Lutz D
Acta Med Austriaca Suppl; 2000; 52():13-5. PubMed ID: 11261271
[TBL] [Abstract][Full Text] [Related]
3. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
4. Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.
Roncella S; Ferro P; Bacigalupo B; Dessanti P; Giannico A; Gorji N; Moroni M; Tozzini S; Pensa F; Gianquinto D; Fais F; Pronzato P; Fedeli F
J Exp Clin Cancer Res; 2006 Mar; 25(1):65-72. PubMed ID: 16761620
[TBL] [Abstract][Full Text] [Related]
5. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
6. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
9. [Mammaglobin mRNA measurement in the detection of micrometastasis in peripheral blood of breast cancer patients].
Liu N; Zhang W; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):317-9. PubMed ID: 11783116
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.
Roncella S; Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Sivori M; Carletti AM; Fontana V; Canessa PA; Pistillo MP; Fedeli F
Diagn Mol Pathol; 2010 Jun; 19(2):92-8. PubMed ID: 20502186
[TBL] [Abstract][Full Text] [Related]
11. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
12. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
[TBL] [Abstract][Full Text] [Related]
14. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
15. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
16. [Expression of human mammaglobin mRNA in peripheral blood of breast cancer and their implication].
Li S; Li J; Luo C; Yu B; An P; Cai H
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):168-70. PubMed ID: 11955406
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumour cell detection in peripheral blood of breast cancer patients.
Zach O; Kasparu H; Wagner H; Krieger O; Lutz D
Acta Med Austriaca Suppl; 2002; 59():32-4. PubMed ID: 12506758
[TBL] [Abstract][Full Text] [Related]
18. Mammaglobin, a potential marker of breast cancer nodal metastasis.
Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]